Skip to content

Tractus Corporation

United StatesFDA applicant, unverified

Devices
2

What Tractus Corporation makes

Tractus Corporation develops software applications for medical imaging workflows, including tools for reviewing and recording tissue mapping data. These solutions are designed to assist in the analysis and documentation of pathological specimens, supporting diagnostic processes in clinical settings.

The company’s products are classified as Class II devices under FDA regulations and are authorised through the 510(k) clearance pathway. The portfolio is listed in the FDA’s 510(k) database, and the manufacturer is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

Frequently asked questions

How many devices does Tractus Corporation have in the registry?

The registry currently lists 2 devices for Tractus Corporation. Devices recorded under merged duplicate company entries are counted once.

Which registries list Tractus Corporation's devices?

Among its 2 most recently registered devices, Tractus Corporation has devices listed in FDA 510(k) (2 devices).

What risk classes do Tractus Corporation's devices fall under?

Among its 2 most recently registered devices, the classes recorded for Tractus Corporation's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Tractus Corporation in the registry?

The most recently registered devices listed for Tractus Corporation include TRACTUS TISSUEMAPPER REVIEWER APPLICATION and TRACTUS TISSUEMAPPER IMAGE RECORDING SYSTEM APPLICATION.

Generated automatically from registry data and not verified by a human reviewer.